• About Us
  • Our Team
  • Advertising
  • Careers
  • Contact
Monday, June 2, 2025
  • Login
No Result
View All Result
Navjeevan Express
Advertisement
  • Gujarat
    • Ahmedabad
    • Vadodara
    • Surat
    • Rajkot
    • Saurashtra
    • Kutch
    • Central Gujarat
    • South Gujarat
  • National
    • Andhra Pradesh
    • Rajasthan
    • Maharashtra
    • Pondicherry
    • Tamil Nadu
    • OTHER STATES
  • Politics
  • Business
    • Companies
    • Personal Finance
  • Sports
    • Cricket
    • Hockey
    • Football
    • Badminton
    • Other Sports
  • Entertainment
    • Arts and Culture
    • Theatre
    • Cinema
    • Photos
    • Videos
  • Lifestyle
    • Fashion
    • Health & Environment
    • Food and Beverages
    • Spirituality
    • Tourism and Travel
  • World
  • More
    • Science and Technology
    • Legal
    • Opinion
    • Student’s Corner
    • Youth
Navjeevan Express
  • Gujarat
    • Ahmedabad
    • Vadodara
    • Surat
    • Rajkot
    • Saurashtra
    • Kutch
    • Central Gujarat
    • South Gujarat
  • National
    • Andhra Pradesh
    • Rajasthan
    • Maharashtra
    • Pondicherry
    • Tamil Nadu
    • OTHER STATES
  • Politics
  • Business
    • Companies
    • Personal Finance
  • Sports
    • Cricket
    • Hockey
    • Football
    • Badminton
    • Other Sports
  • Entertainment
    • Arts and Culture
    • Theatre
    • Cinema
    • Photos
    • Videos
  • Lifestyle
    • Fashion
    • Health & Environment
    • Food and Beverages
    • Spirituality
    • Tourism and Travel
  • World
  • More
    • Science and Technology
    • Legal
    • Opinion
    • Student’s Corner
    • Youth
No Result
View All Result
Navjeevan Express
No Result
View All Result
ADVERTISEMENT
Home National Gujarat Ahmedabad

Q1FY25 results: Zydus Lifesciences net profit rises 31% to Rs 1,420 cr

by Nav Jeevan
10 months ago
in Ahmedabad, America, Breaking News, Business, Financial Results, Gujarat, Health & Environment, National, Pharma
Reading Time: 2 mins read
0
0
Q1FY25 results: Zydus Lifesciences net profit rises 31% to Rs 1,420 cr

Representational image

ADVERTISEMENT
  • Company receives USFDA approval for Valbenazine Capsules
  • Revenue from operations at Rs. 62,075 mn, up 21% YoY
  • Research & Development (R&D) investments for the quarter stood at Rs. 3,925 mn (6.3% of revenues)

NE BUSINESS BUREAU

AHMEDABAD, AUGUST 11

Zydus Lifesciences Limited on Friday said its consolidated net profit increased 31 per cent year on year to Rs 1,420 crore in the first quarter ended June 2024 on the back of robust sales.

The drug maker had reported a net profit of Rs 1,087 crore in the April-June quarter of last fiscal.

Revenue from operations rose to Rs 6,207 crore in the period under review as compared to Rs 5,140 crore in the June quarter of FY24, Zydus Lifesciences said in a statement.

“Sustained growth momentum across our businesses along with enhanced profitability drove our strong Q1 performance,” Zydus Lifesciences Managing Director Sharvil Patel said.

Execution success of company’s differentiated pipeline in the US and outperformance of India geography business were particularly noteworthy, he added.

“We are on course to achieve our growth aspirations for FY25 and are committed to investing in sustainable growth initiatives and innovative solutions for the future,” Patel said.

The company said its India sales stood at Rs 2,212 crore in the June quarter, up 15 per cent, as compared to Rs 1,921 crore in the year-ago period.

The US formulation sales stood at Rs 3,093 crore in first quarter, up 26 per cent year on year as against Rs 2,454 crore in the year-ago period.

Q1 FY25 Consolidated Financial Results

Rs. mn Q1

FY25

Q1

FY24

% Gr.
YoY
Q4

FY24

% Gr.
QoQ
Revenue from operations 62,075 51,396 20.8% 55,338 12.2%
EBITDA 20,840 15,053 38.4% 16,305 27.8%
EBITDA margin (%) 33.6% 29.3% 29.5%  
PBT 18,997 13,292 42.9% 15,470 22.8%
Net Profit 14,199 10,869 30.6% 11,823 20.1%

Zydus receives USFDA approval for Valbenazine Capsules

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Valbenazine Capsules, 40 mg, 60 mg, and 80 mg (USRLD: Ingrezza Capsules).

Valbenazine Capsules are indicated for the treatment of adults with tardive dyskinesia (uncontrollable movement of the face, tongue, or other body parts).

The drug will be manufactured at the group’s formulation manufacturing facility in Ahmedabad SEZ – II, India.

Zydus was one of the first ANDA applicants to submit a substantially complete ANDA with a paragraph IV certification for Valbenazine Capsules, 40 mg, and 80 mg, and was the first ANDA applicant to submit a substantially complete ANDA with a paragraph IV certification for Valbenazine Capsules, 60 mg.

With this approval, Zydus is eligible for 180 days of shared generic drug exclusivity for Valbenazine Capsules, 40 mg, and 80 mg, and is eligible for 180 days of sole generic drug exclusivity for Valbenazine Capsules, 60 mg.

Valbenazine Capsules had annual sales of USD 1993.6 mn in the United States (IQVIA MAT June 2024).

 

 

Tags: 31approvalnet profitQ1FY25resultsrisesRs 1420 crusfdaValbenazine CapsulesZydus Lifesciences
ADVERTISEMENT
Previous Post

Canadian Wood hosts insightful seminar on Building with Sustainable and Certified Wood

Next Post

Varalakshmi Vratam fete at Padmavathi temple in Tiruchanoor on Friday

Nav Jeevan

Nav Jeevan

Next Post
Varalakshmi Vratam fete at Padmavathi temple in Tiruchanoor on Friday

Varalakshmi Vratam fete at Padmavathi temple in Tiruchanoor on Friday

Prashanth commences second innings with ‘Andhagan’ and delivers his best

Prashanth commences second innings with ‘Andhagan’ and delivers his best

ADVERTISEMENT

Recommended

Shiv Nadar University launches Online Certification Programme in Data Sciences and Analytics for Business

Shiv Nadar University launches Online Certification Programme in Data Sciences and Analytics for Business

5 years ago
120-year old City Union Bank sweeps all 7 awards at 19th Banking Technology Conference of IBA

120-year old City Union Bank sweeps all 7 awards at 19th Banking Technology Conference of IBA

1 year ago
ADVERTISEMENT

Recent Posts

  • Reliance Retails’ Hamleys brings its magic to Kuwait: Iconic brand opens its 9th store in the GCC
  • Govt notifies guidelines for scheme to promote manufacturing of electric passenger cars
  • Dream Foundation-TTEC India Foundation distribute free educational kits to 200 underprivileged kids

Category

Select Category

    Contact Us

    Email:
    ne.gowri1964@gmail.com

    Phone:
    9643255068

    Live Visitors

    • About Us
    • Our Team
    • Advertising
    • Careers
    • Contact

    © 2021 all right reserved by Navjeevanexpress.com. Consulted by MediaHives.com

    No Result
    View All Result
    • Gujarat
      • Ahmedabad
      • Vadodara
      • Surat
      • Rajkot
      • Saurashtra
      • Kutch
      • Central Gujarat
      • South Gujarat
    • National
      • Andhra Pradesh
      • Rajasthan
      • Maharashtra
      • Pondicherry
      • Tamil Nadu
      • OTHER STATES
    • Politics
    • Business
      • Companies
      • Personal Finance
    • Sports
      • Cricket
      • Hockey
      • Football
      • Badminton
      • Other Sports
    • Entertainment
      • Arts and Culture
      • Theatre
      • Cinema
      • Photos
      • Videos
    • Lifestyle
      • Fashion
      • Health & Environment
      • Food and Beverages
      • Spirituality
      • Tourism and Travel
    • World
    • More
      • Science and Technology
      • Legal
      • Opinion
      • Student’s Corner
      • Youth

    © 2021 all right reserved by Navjeevanexpress.com. Consulted by MediaHives.com

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In